PMID- 18190896 OWN - NLM STAT- MEDLINE DCOM- 20080603 LR - 20191210 IS - 0006-8993 (Print) IS - 0006-8993 (Linking) VI - 1193 DP - 2008 Feb 8 TI - Protective effect of nitric oxide synthase inhibition or antioxidants on brain oxidative damage caused by intracerebroventricular arginine administration. PG - 120-7 LID - 10.1016/j.brainres.2007.11.052 [doi] AB - We have previously demonstrated that acute arginine administration induces oxidative stress and compromises energy metabolism in rat hippocampus. In the present study, we initially investigated the effect of intracerebroventricular infusion of arginine (0.1, 0.5 and 1.5 mM solution) on Na(+),K(+)-ATPase activity and on some parameters of oxidative stress, namely thiobarbituric acid-reactive substances (TBA-RS) and total radical-trapping antioxidant parameter (TRAP) in the hippocampus of rats. Results showed that 1.5 mM arginine solution significantly increases TBA-RS and reduces Na(+),K(+)-ATPase activity and TRAP in the rat hippocampus. We also evaluated the influence of the nitric oxide synthase inhibitor, N(omega)-nitro-L-arginine methyl ester (L-NAME), and antioxidants, namely alpha-tocopherol plus ascorbic acid, on the effects elicited by arginine on Na(+),K(+)-ATPase activity, TBA-RS and TRAP. Results showed that treatment with alpha-tocopherol plus ascorbic acid per se did not alter these parameters but prevented these effects. Furthermore, intracerebroventricular infusion of L-NAME prevented the inhibition caused by arginine on Na(+),K(+)-ATPase activity, as well as the increased of TBA-RS. Our findings indicate that intracerebroventricular infusion of arginine induces oxidative stress in rat hippocampus and that the inhibition of Na(+),K(+)-ATPase activity caused by this amino acid was probably mediated by NO and/or its derivatives ONOO(-) and/or other free radicals. Finally, we suggest that the administration of antioxidants should be considered as an adjuvant therapy to specific diets in hyperargininemia. FAU - Delwing, Debora AU - Delwing D AD - Departamento de Bioquimica, Instituto de Ciencias Basicas da Saude, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos, 2600-Anexo, CEP 90035-003, Porto Alegre, RS, Brazil. FAU - Delwing, Daniela AU - Delwing D FAU - Bavaresco, Caren S AU - Bavaresco CS FAU - Wyse, Angela T S AU - Wyse AT LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20071205 PL - Netherlands TA - Brain Res JT - Brain research JID - 0045503 RN - 0 (Amidines) RN - 0 (Antioxidants) RN - 0 (Enzyme Inhibitors) RN - 0 (Thiobarbituric Acid Reactive Substances) RN - 7381JDR72F (2,2'-azobis(2-amidinopropane)) RN - 94ZLA3W45F (Arginine) RN - EC 7.2.2.13 (Sodium-Potassium-Exchanging ATPase) RN - H4N855PNZ1 (alpha-Tocopherol) RN - PQ6CK8PD0R (Ascorbic Acid) RN - V55S2QJN2X (NG-Nitroarginine Methyl Ester) SB - IM MH - Amidines/metabolism MH - Analysis of Variance MH - Animals MH - Antioxidants/*therapeutic use MH - Arginine/administration & dosage MH - Ascorbic Acid/therapeutic use MH - Brain Injuries/chemically induced/pathology/*prevention & control MH - Disease Models, Animal MH - Dose-Response Relationship, Drug MH - Drug Interactions MH - Enzyme Inhibitors/*therapeutic use MH - Hippocampus/drug effects/metabolism MH - Injections, Intraventricular/methods MH - Male MH - NG-Nitroarginine Methyl Ester/*therapeutic use MH - Oxidative Stress/*drug effects MH - Rats MH - Rats, Wistar MH - Sodium-Potassium-Exchanging ATPase/metabolism MH - Thiobarbituric Acid Reactive Substances/metabolism MH - alpha-Tocopherol/therapeutic use EDAT- 2008/01/15 09:00 MHDA- 2008/06/05 09:00 CRDT- 2008/01/15 09:00 PHST- 2007/10/02 00:00 [received] PHST- 2007/11/23 00:00 [revised] PHST- 2007/11/27 00:00 [accepted] PHST- 2008/01/15 09:00 [pubmed] PHST- 2008/06/05 09:00 [medline] PHST- 2008/01/15 09:00 [entrez] AID - S0006-8993(07)02858-2 [pii] AID - 10.1016/j.brainres.2007.11.052 [doi] PST - ppublish SO - Brain Res. 2008 Feb 8;1193:120-7. doi: 10.1016/j.brainres.2007.11.052. Epub 2007 Dec 5.